Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver
Open Access
- 22 March 2005
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 92 (7) , 1268-1272
Abstract
The largest single underlying cause of hepatocellular carcinoma (HCC) worldwide is hepatitis B virus (HBV) infection. Hepatitis B virus increases cellular oxidative stress and the development of HCC occurs after a long latency period. The study was carried out to determine whether mitochondrial DNA abnormalities were associated with HCC in individuals with HBV. The frequency of mutation and deletion of specific areas of the mitochondrial genome in tumour and matched normal tissue of patients with HBV infection was investigated in the current study. The percentage of control subjects harbouring D-loop mutations was 11%, which was significantly lower than that observed in both the noncancerous (49%, P=0.033) and tumour tissue (59%, P=0.014) of patients with HCC. In contrast, the number of cases in which the common 4977 bp deletion of the mitochondrial genome was detected was significantly greater in control liver and noncancerous liver tissue of subjects with HCC (100 and 95%, respectively) than in cancerous liver tissue (28%, P<0.001). These observations suggest that the inflammatory process contributes to the rate of mitochondrial mutations. However, the lower frequency of the large deletion in cancerous tissue suggests that there is selection against either mitochondria, which harbour large deletions, or against cells that contain these mitochondria during hepatocarcinogenesis.Keywords
This publication has 21 references indexed in Scilit:
- Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinomaBritish Journal of Cancer, 2004
- Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinomaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Angiogenesis inhibitors in clinical development; where are we now and where are we going?British Journal of Cancer, 2004
- Viral hepatitis BThe Lancet, 2003
- Molecular viral oncology of hepatocellular carcinomaOncogene, 2003
- Regulatory mechanisms of viral hepatitis B and CJournal of Biosciences, 2003
- Maintenance of mitochondrial DNA integrity: repair and degradationCurrent Genetics, 2002
- Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagusOncogene, 2002
- Mitochondrial DNA Somatic Mutations (Point Mutations and Large Deletions) and Mitochondrial DNA Variants in Human Thyroid PathologyThe American Journal of Pathology, 2002
- The mitochondrial theory of aging: Do damaged mitochondria accumulate by delayed degradation?Experimental Gerontology, 1999